Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.4K
Overview
44.4K
Cancer Vaccines01:30

Cancer Vaccines

358
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
358
Cross-reactivity00:42

Cross-reactivity

31.0K
Overview
31.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized Trial.

Pediatrics·2026
Same author

A Phase 3 study to assess the safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) co-administered with routine pediatric vaccines in healthy infants in the USA and Puerto Rico.

Human vaccines & immunotherapeutics·2025
Same author

Baptism in a Pandemic: Infectious Diseases Clinical Research Consortium Network Design for Readiness and Response.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Evaluation of Cellular Immune Responses After mRNA-1273 Vaccination in Children 6 Months to 11 Years of Age.

The Journal of infectious diseases·2025
Same author

Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients.

Critical care explorations·2024
Same author

February 2024 ACIP Meeting Update: Meningococcal, RSV, COVID-19, and Other Vaccines.

Pediatrics·2024

Related Experiment Video

Updated: Jun 26, 2025

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

17.0K

Vaccine Development.

Elizabeth A D Hammershaimb1, James D Campbell1

  • 1Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 West Baltimore Street, Room 480, Baltimore, MD 21201, USA; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA.

Pediatric Clinics of North America
|May 16, 2024
PubMed
Summary

This article reviews ethical considerations for pediatric vaccine development during pandemics. It examines historical vaccine examples and the current status of pandemic preparedness vaccines.

Keywords:
AnthraxCOVID-19EbolaEmerging infectionsInfluenzaMpoxPediatric vaccinesSmallpox

More Related Videos

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

21.9K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.5K

Related Experiment Videos

Last Updated: Jun 26, 2025

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

17.0K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

21.9K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.5K

Area of Science:

  • Vaccinology
  • Public Health Ethics
  • Epidemiology

Background:

  • Pandemic preparedness necessitates robust pediatric vaccine development strategies.
  • Historical pandemics like smallpox, influenza, and COVID-19 highlight the need for child-focused vaccine solutions.
  • Ethical considerations are paramount in the development and deployment of pediatric vaccines.

Observation:

  • Examined historical pediatric vaccine development during past pandemics.
  • Assessed current vaccine development for pandemic preparedness, including vaccines for smallpox/mpox, influenza, anthrax, and Ebola.
  • Reviewed vaccines targeting World Health Organization priority pathogens.

Findings:

  • Pediatric vaccine development for pandemics involves complex ethical considerations.
  • Historical data provides insights into challenges and successes in pediatric vaccine deployment.
  • The US Strategic National Stockpile includes key pandemic vaccines, with ongoing development for emerging threats.

Implications:

  • Ensuring ethical frameworks for pediatric vaccine development is crucial for future pandemic response.
  • Strengthening the pipeline for pediatric pandemic vaccines improves global health security.
  • Continued research and ethical oversight are vital for equitable access to life-saving vaccines for children.